Web
Site
Home
About Us
Company Profile
Recognition
Management
Adnan M. M. Mjalli
Stephen L. Holcombe
Stephen J. Ireland
Robert C. Andrews
Jane M. Shen
Carmen Valcarce
Matthew Kostura
Samuel B. Rollins
David Clark
Our Affiliates
High Point Pharmaceuticals
High Point Clinical Trials Center
Board of Directors
Adnan M. M. Mjalli
Ronald O. Perelman
Paul G. Savas
Barry F. Schwartz
Thomas R.B. Wardell
Scientific Advisors
David Stern
Anne Marie Schmidt
Stanley M. Roberts
George D. Demetri
Larry Mylari
Eliot H. Ohlstein
Mark Hannink
Donna M. Wilcock
Contact Us
Therapeutic Areas
Alzheimer’s Disease
TTP488
TTP4000
HPP854
Metabolic Disorders
Diabetes
TTP399
TTP814
TTP054
Dyslipidemia
HPP593
Obesity
HPP404
Metabolic Syndrome
HPP593
Primary Open Angle Glaucoma
HPP851
Respiratory/Inflammation
HPP737
Cancer
TTP607
Cancer Metabolism
Healthy Aging
Discovery Platform
TTP Translational Technology
TTPSpace
TTPScreen
TTPredict
TTPost Gene
TTPSite
TTPDock
TTPSelect
Strategic Alliances
Press Releases
2011
2011-05-19 TransTech Pharma Press Release
2010
2010-06-08 TransTech Pharma, Inc.
2010-11-4 News Release
2009
2008
2008-01-25 News Release
2007
2007-12-21 News Release
2007-12-18 The Business Journal
2007-02-22 BioWorld Today
2007-02-20 TransTech Pharma, Inc.
2006
2006-09-18 TransTech Pharma, Inc.
2005
2005-02-15 TransTech Pharma, Inc.
2005-09-22 TransTech Pharma, Inc.
2005-12-21 TransTech Pharma, Inc.
2004
2004-10-26 TransTech Pharma, Inc.
2004-09-08 TransTech Pharma, Inc.
2004-07-11 TransTech Pharma, Inc.
2004-05-11 TransTech Pharma, Inc.
2004-05-10 TransTech Pharma, Inc
Our Affiliates
Affiliates
High Point Pharmaceuticals LLC.
High Point Clinical Trials Center (HPCTC)
Home
|
About Us
|
Therapeutic Areas
|
Discovery Platform
|
Strategic Alliances
|
Press Releases
|
Careers
|
Contact Us
|
Login
© Copyright 2011,Transtech Pharma, Inc., all rights reserved. ® Marks owned by TransTech Pharma, Inc.
Web Design and Development by
BEM Interactive